Hendrée E Jones1,2, Carl Seashore3, Elisabeth Johnson1, Evette Horton1, Kevin E O'Grady4, Kim Andringa1, Matthew R Grossman5, Bonny Whalen6, Alison Volpe Holmes6. 1. UNC Horizons and Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 2. Departments of Psychiatry and Obstetrics and Gynecology, School of Medicine, Johns Hopkins University, Baltimore, Maryland. 3. Department of Pediatrics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 4. Department of Psychology, University of Maryland, College Park, College Park, Maryland. 5. Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut. 6. Department of Pediatrics, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
Abstract
BACKGROUND AND OBJECTIVES: The present study examined the psychometric characteristics of the Neonatal Abstinence Scoring System (NASS; "Finnegan Scale") and the MOTHER NAS Scale (MNS). METHODS: Secondary analysis of data from 131 neonates from the Maternal Opioid Treatment: Human Experimental Research (MOTHER) study, a randomized trial in opioid-dependent pregnant women administeredbuprenorphine or methadone. RESULTS: Both the NASS and MNS demonstrated poor psychometric properties, with internal consistency (Cronbach's αs) failing to exceed .62 at first administration, peak NAS score, and NAS treatment initiation. CONCLUSIONS: Findings support the need for development of a NAS measure based on sound psychometric principles. SCIENTIFIC SIGNIFICANCE: This study found that two frequently used measures of neonatal abstinence syndrome suffer inadequacies in regard to their basic measurement characteristics. (Am J Addict 2016;25:370-373).
RCT Entities:
BACKGROUND AND OBJECTIVES: The present study examined the psychometric characteristics of the Neonatal Abstinence Scoring System (NASS; "Finnegan Scale") and the MOTHER NAS Scale (MNS). METHODS: Secondary analysis of data from 131 neonates from the Maternal Opioid Treatment: Human Experimental Research (MOTHER) study, a randomized trial in opioid-dependent pregnant women administered buprenorphine or methadone. RESULTS: Both the NASS and MNS demonstrated poor psychometric properties, with internal consistency (Cronbach's αs) failing to exceed .62 at first administration, peak NAS score, and NAS treatment initiation. CONCLUSIONS: Findings support the need for development of a NAS measure based on sound psychometric principles. SCIENTIFIC SIGNIFICANCE: This study found that two frequently used measures of neonatal abstinence syndrome suffer inadequacies in regard to their basic measurement characteristics. (Am J Addict 2016;25:370-373).
Authors: E Gomez-Pomar; A Christian; L Devlin; K T Ibonia; V A Concina; H Bada; P M Westgate Journal: J Perinatol Date: 2017-04-06 Impact factor: 2.521
Authors: Leslie W Young; Songthip Ounpraseuth; Stephanie L Merhar; Alan E Simon; Abhik Das; Rachel G Greenberg; Rosemary D Higgins; Jeannette Lee; Brenda B Poindexter; P Brian Smith; Michele Walsh; Jessica Snowden; Lori A Devlin Journal: Trials Date: 2022-08-09 Impact factor: 2.728
Authors: Stacey L Klaman; Krystyna Isaacs; Anne Leopold; Joseph Perpich; Susan Hayashi; Jeff Vender; Melinda Campopiano; Hendrée E Jones Journal: J Addict Med Date: 2017 May/Jun Impact factor: 3.702
Authors: Enrique Gomez Pomar; Loretta P Finnegan; Lori Devlin; Henrietta Bada; Vanessa A Concina; Katrina T Ibonia; Philip M Westgate Journal: BMJ Open Date: 2017-09-27 Impact factor: 2.692